Hymenoptera venom allergy

References

• Müller UR. Insect sting allergy. In: Clinical Picture, Diagnosis and Treatment. Gustav Fischer Verslag, Germany (1990).
   Google Scholar
• Kochuyt AM, Van Hoeyveld E, Stevens EA. Occupational allergy to bumble bee venom. Clin. Exp. Allergy 23(3), 190–195 (1993).
   PubMedGoogle Scholar
• de Groot H, de Graaf-in ‘t Veld C, van Wijk RG. Allergy to bumblebee venom. I. Occupational anaphylaxis to bumblebee venom: diagnosis and treatment. Allergy 50(7), 581–584 (1995).
   PubMedGoogle Scholar
• Brown SG, Franks RW, Baldo BA, Heddle RJ. Prevalence, severity, and natural history of jack jumper ant venom allergy in Tasmania. J. Allergy Clin. Immunol.111(1), 187–192 (2003).
   PubMed Web of Science ®Google Scholar
• Shek LP, Ngiam NS, Lee BW. Ant allergy in Asia and Australia. Curr. Opin. Allergy Clin. Immunol. 4(4), 325–328 (2004).
   PubMedGoogle Scholar
• Golden DB, Marsh DG, Kagey-Sobotka A et al. Epidemiology of insect venom sensitivity. J. Am. Med. Assoc. 262(2), 240–244 (1989).
   PubMed Web of Science ®Google Scholar
• Schafer T, Przybilla B. IgE antibodies to hymenoptera venoms in the serum are common in the general population and are related to indications of atopy. Allergy 51(6), 372–377 (1996).
   PubMedGoogle Scholar
• Shimizu T, Hori T, Tokuyama K, Morikawa A, Kuroume T. Clinical and immunologic surveys of hymenoptera hypersensitivity in Japanese forestry workers. Ann. Allergy Asthma Immunol. 74(6), 495–500 (1995).
   PubMedGoogle Scholar
• Annila IT, Karjalainen ES, Morsky P, Kuusisto PA. Clinical symptoms and immunologic reactivity to bee and wasp stings in beekeepers. Allergy 50(7), 568–574 (1995).
   PubMed Web of Science ®Google Scholar
• Antonicelli L, Bilo MB, Bonifazi F. Epidemiology of hymenoptera allergy. Curr. Opin. Allergy Clin. Immunol. 2(4), 341–346 (2002).
   PubMedGoogle Scholar
• Annila I. Bee venom allergy. Clin. Exp. Allergy 30(12), 1682–1687 (2000).
   PubMed Web of Science ®Google Scholar
• Fricker M, Helbling A, Schwartz L, Muller U. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients. J. Allergy Clin. Immunol.100(1), 11–15 (1997).
   PubMedGoogle Scholar
• Ludolph-Hauser D, Rueff F, Fries C, Schopf P, Przybilla B. Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to hymenoptera stings. Lancet 357(9253), 361–362 (2001).
   PubMed Web of Science ®Google Scholar
• Vetter RS, Visscher PK, Camazine S. Mass envenomations by honey bees and wasps. West J. Med. 170(4), 223–227 (1999).
   PubMedGoogle Scholar
• Muller U, Mosbech H. Position paper. Immunotherapy with hymenoptera venoms. Allergy 48, S37–S46 (1993).
   PubMedGoogle Scholar
• Schwartz HJ, Squillace DL, Sher TH, Teigland JD, Yunginger JW. Studies in stinging insect hypersensitivity: postmortem demonstration of antivenom IgE antibody in possible sting-related sudden death. Am. J. Clin. Pathol. 85(5), 607–610 (1986).
   PubMedGoogle Scholar
• Schuberth KC, Lichtenstein LM, Kagey-Sobotka A, Szklo M, Kwiterovich KA, Valentine MD. Epidemiologic study of insect allergy in children. II. Effect of accidental stings in allergic children. J. Pediatr. 102(3), 361–365 (1983).
   PubMedGoogle Scholar
• Blaauw PJ, Smithuis LO. The evaluation of the common diagnostic methods of hypersensitivity for bee and yellow jacket venom by means of an in-hospital insect sting. J. Allergy Clin. Immunol.75(5), 556–562 (1985).
   PubMed Web of Science ®Google Scholar
• GraftDF, Schuberth KC, Kagey-Sobotka A et al.A prospective study of the natural history of large local reactions after hymenoptera stings in children. J.Pediatr.104(5), 664–668 (1984).
   Google Scholar
• Schultze-Werninghaus C, Wahn U, Niggemann B. Evaluation of the risk of anaphylactic reactions by wasp venom-extract challenges in children. Pediatr. Allergy Immunol. 10(2), 133–137 (1999).
   PubMedGoogle Scholar
• Golden DB, Kagey-Sobotka A, Norman PS, Hamilton RG, Lichtenstein LM. Outcomes of allergy to insect stings in children, with and without venom immunotherapy. N. Engl. J. Med. 351(7), 668–674 (2004).
   PubMed Web of Science ®Google Scholar
• Franken HH, Dubois AE, Minkema HJ, van der Heide S, de Monchy JG. Lack of reproducibility of a single negative sting challenge response in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity. J. Allergy Clin. Immunol.93(2), 431–436 (1994).
   PubMedGoogle Scholar
• van der Zwan J, van der Linden PW. Anaphylactic reactions to bee or wasp stings: results of 308 sting provocations. Schweiz Med. Wochenschr. 121(Suppl. 40/I), 60 (1991).
   Google Scholar
• Day JH, Buckeridge DL, Welsh AC. Risk assessment in determining systemic reactivity to honeybee stings in sting-threatened individuals. J. Allergy Clin. Immunol.93(4), 691–705 (1994).
   PubMedGoogle Scholar
• Golden DB, Kagey-Sobotka A, Norman PS, Hamilton RG, Lichtenstein LM. Insect sting allergy with negative venom skin test responses. J. Allergy Clin. Immunol.107(5), 897–901 (2001).
   PubMed Web of Science ®Google Scholar
• Golden DB, Tracy JM, Freeman TM, Hoffman DR. Negative venom skin test results in patients with histories of systemic reaction to a sting. J. Allergy Clin. Immunol.112(3), 495–498 (2003).
   PubMed Web of Science ®Google Scholar
• Leimgruber A, Lantin JP, Frei PC. Comparison of two in vitro assays, RAST and CAP, when applied to the diagnosis of anaphylactic reactions to honeybee or yellow jacket venoms. Correlation with history and skin tests. Allergy 48(6), 415–420 (1993).
   PubMedGoogle Scholar
• Egner W, Ward C, Brown DL, Ewan PW. The frequency and clinical significance of specific IgE to both wasp (Vespula) and honey-bee (Apis) venoms in the same patient. Clin. Exp. Allergy 28(1), 26–34 (1998).
   PubMed Web of Science ®Google Scholar
• Hemmer W, Focke M, Kolarich D et al. Antibody binding to venom carbohydrates is a frequent cause for double positivity to honeybee and yellow jacket venom in patients with stinging-insect allergy. J. Allergy Clin. Immunol.108(6), 1045–1052 (2001).
   PubMed Web of Science ®Google Scholar
• van Halteren HK, van der Linden PW, Burgers SA, Bartelink AK. Hymenoptera sting challenge of 348 patients: relation to subsequent field stings. J. Allergy Clin. Immunol.97(5), 1058–1063 (1996).
   PubMedGoogle Scholar
• Dubois AE. Investigational and clinical use of the sting challenge. Curr. Opin. Allergy Clin. Immunol. 3(4), 283–285 (2003).
   PubMedGoogle Scholar
• Rueff F, Przybilla B, Muller U, Mosbech H. The sting challenge test in hymenoptera venom allergy. Position paper of the Subcommittee on Insect Venom Allergy of the European Academy of Allergology and Clinical Immunology. Allergy 51(4), 216–225 (1996).
   PubMed Web of Science ®Google Scholar
• Bilo MB, Brianzoni MF, Garritani MS, Antonicelli L, Farabollini B, Bonifazi F. The sting challenge test in hymenoptera venom allergy: pros and cons. Allergy Immunol. (Paris)35(10), 377–381 (2003).
   Google Scholar
• Muller UR. Recombinant hymenoptera venom allergens. Allergy 57(7), 570–576 (2002).
   PubMed Web of Science ®Google Scholar
• Jeep S, Paul M, Muller U, Kunkel G. Honeybee venom allergy: immunoblot studies in allergic patients after immunotherapy and before sting challenge. Allergy 51(8), 540–546 (1996).
   PubMed Web of Science ®Google Scholar
• Zollner TM, Spengler K, Podda M, Ergezinger K, Kaufmann R, Boehncke WH. The western blot is a highly sensitive and efficient technique in diagnosing allergy to wasp venom. Clin. Exp. Allergy 31(11), 1754–1761 (2001).
   PubMed Web of Science ®Google Scholar
• Maly FE, Marti-Wyss S, Blumer S, Cuhat-Stark I, Wuthrich B. Mononuclear blood cell sulfidoleukotriene generation in the presence of interleukin-3 and whole blood histamine release in honey bee and yellow jacket venom allergy. J. Investig. Allergol. Clin. Immunol. 7(4), 217–224 (1997).
   PubMedGoogle Scholar
• Sainte-Laudy J, Sabbah A, Drouet M, Lauret MG, Loiry M. Diagnosis of venom allergy by flow cytometry. Correlation with clinical history, skin tests, specific IgE, histamine and leukotriene C4 release. Clin. Exp. Allergy 30(8), 1166–1171 (2000).
   PubMed Web of Science ®Google Scholar
• Binder M, Fierlbeck G, King T, Valent P, Buhring HJ. Individual hymenoptera venom compounds induce upregulation of the basophil activation marker ectonucleotide pyrophosphatase/ phosphodiesterase 3 (CD203c) in sensitized patients. Int. Arch. Allergy Immunol. 129(2), 160–168 (2002).
   PubMedGoogle Scholar
• Erdmann SM, Sachs B, Kwiecien R, Moll-Slodowy S, Sauer I, Merk HF. The basophil activation test in wasp venom allergy: sensitivity, specificity and monitoring specific immunotherapy. Allergy 59(10), 1102–1109 (2004).
   PubMed Web of Science ®Google Scholar
• Schumacher MJ, Tveten MS, Egen NB. Rate and quantity of delivery of venom from honeybee stings. J. Allergy Clin. Immunol.93(5), 831–835 (1994).
   PubMed Web of Science ®Google Scholar
• Simons FE. First-aid treatment of anaphylaxis to food: focus on epinephrine. J. Allergy Clin. Immunol.113(5), 837–844 (2004). Erratum: J. Allergy Clin. Immunol. 113, 1039 (2004).
   PubMed Web of Science ®Google Scholar
• Chamberlain D. Emergency medical treatment of anaphylactic reactions. Project Team of the Resuscitation Council (UK). J. Accid. Emerg. Med. 16(4), 243–247 (1999).
   PubMedGoogle Scholar
• Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J. Allergy Clin. Immunol.110(3), 341–348 (2002).
   PubMed Web of Science ®Google Scholar
• Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis. J. Allergy Clin. Immunol.101(6 Pt 2), S465–S528 (1998).
   PubMed Web of Science ®Google Scholar
• Akdis CA, Blaser K. Mechanisms of allergen-specific immunotherapy. Allergy 55(6), 522–530 (2000).
   PubMed Web of Science ®Google Scholar
• Akdis CA, Joss A, Akdis M, Blaser K. Mechanism of IL-10-induced T-cell inactivation in allergic inflammation and normal response to allergens. Int. Arch. Allergy Immunol. 124(1–3), 180–182 (2001).
   PubMed Web of Science ®Google Scholar
• Ewan PW. New insight into immunological mechanisms of venom immunotherapy. Curr. Opin. Allergy Clin. Immunol. 1(4), 367–374 (2001).
   PubMedGoogle Scholar
• Taylor A, Verhagen J, Akdis CA, Akdis M. T regulatory cells in allergy and health: a question of allergen specificity and balance. Int. Arch. Allergy Immunol. 135(1), 73–82 (2004).
   PubMed Web of Science ®Google Scholar
• Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Muller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-g secretion in specific allergen-stimulated T-cell cultures. J. Immunol. 154(8), 4187–4194 (1995).
   PubMed Web of Science ®Google Scholar
• Bellinghausen I, Metz G, Enk AH, Christmann S, Knop J, Saloga J. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur. J. Immunol. 27(5), 1131–1139 (1997).
   PubMed Web of Science ®Google Scholar
• Schuerwegh AJ, De Clerck LS, Bridts CH, Stevens WJ. Wasp venom immunotherapy induces a shift from IL-4-producing towards interferon-g-producing CD4+ and CD8+ T-lymphocytes. Clin. Exp. Allergy 31(5), 740–746 (2001).
   PubMed Web of Science ®Google Scholar
• Jutel M, Muller UR, Fricker M, Rihs S, Pichler WJ, Dahinden C. Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils. Clin. Exp. Allergy 26(10), 1112–1118 (1996).
   PubMed Web of Science ®Google Scholar
• Stevens WJ, Ebo DG, De Clerck LS, Bridts CH, De Gendt CM, Mertens AV. Evolution of lymphocyte transformation to wasp venom antigen during immunotherapy for wasp venom anaphylaxis. Clin. Exp. Allergy 28(2), 249–252 (1998).
   PubMedGoogle Scholar
• Oude Elberink JN, de Monchy JG, van der HS, Guyatt GH, Dubois AE. Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom. J. Allergy Clin. Immunol.110(1), 174–182 (2002).
   PubMedGoogle Scholar
• Oude Elberink JN, Dubois AE. Quality of life in insect venom allergic patients. Curr. Opin. Allergy Clin. Immunol. 3(4), 287–293 (2003).
   PubMedGoogle Scholar
• Moffitt JE, Golden DB, Reisman RE et al. Stinging insect hypersensitivity: a practice parameter update. J. Allergy Clin. Immunol.114(4), 869–886 (2004).
   PubMed Web of Science ®Google Scholar
• Golden DB, Kwiterovich KA, Kagey-Sobotka A, Lichtenstein LM. Discontinuing venom immunotherapy: extended observations. J. Allergy Clin. Immunol.101(3), 298–305 (1998).
   PubMed Web of Science ®Google Scholar
• Graft DF. Venom immunotherapy: when to start, when to stop. Allergy Asthma Proc. 21(2), 113–116 (2000).
   PubMedGoogle Scholar
• Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein LM. A controlled trial of immunotherapy in insect hypersensitivity. N. Engl. J. Med. 299(4), 157–161 (1978).
   PubMed Web of Science ®Google Scholar
• Muller U, Thurnheer U, Patrizzi R, Spiess J, Hoigne R. Immunotherapy in bee sting hypersensitivity. Bee venom versus wholebody extract. Allergy 34(6), 369–378 (1979).
   PubMed Web of Science ®Google Scholar
• Brown SG, Wiese MD, Blackman KE, Heddle RJ. Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial. Lancet 361(9362), 1001–1006 (2003).
   PubMed Web of Science ®Google Scholar
• Mosbech H, Muller U. Side effects of insect venom immunotherapy: results from an EAACI multicenter study. European Academy of Allergology and Clinical Immunology. Allergy 55(11), 1005–1010 (2000).
   PubMed Web of Science ®Google Scholar
• Rueff F, Wolf H, Schnitker J, Ring J, Przybilla B. Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations. Allergy 59(6), 589–595 (2004).
   PubMedGoogle Scholar
• Simons FE. First-aid treatment of anaphylaxis to food: focus on epinephrine. J. Allergy Clin. Immunol.113(5), 837–844 (2004).
   PubMed Web of Science ®Google Scholar